Korean J Nephrol.
1997 Jun;16(2):412-416.
Myelodysplastic Syndrome in a Renal Transplant Recipient Treated with Long-term Azathioprine
- Affiliations
-
- 1Department of Internal Medicine, Catholic University Medical College, Seoul, Korea.
Abstract
- A 39-year-old renal transplant recipient was admitted for evaluation of pancytopenia which developed gradually 10 months ago. He received renal transplantation 10 years ago and maintained relatively good renal function. Since 1 year before admission, he showed progressive decline of hematocrit, WBC count and platelet. Initial bone marrow biopsy showed erythroid hypoplasia, and second bone marrow biopsy revealed myelodysplasia. Clinical course was fatal. In conclusion, if patients with long term azathioprine treatment show progressive pancytopenia, one should suspect the possibility of myelodysplastic syndrome.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Spontaneous Cauda Equina Syndrome in a Renal Transplant Patient with Long-term Azathioprine Treatment
- A Case of Myelodysplastic Syndrome in a Renal Transplant Recipient
- Mycophenolate Mofetil Versus Azathioprine in Cyclosporine Based Triple Immunosuppression
- Azathioprine-induced Myelodysplasia Mimicking Myelodysplastic Syndrome
- Analysis of Long Term Follow Up Result between Cycolosporine Based Azathioprine versus Mycophenolate Mofetil Groups Randomized after Renal Transplant
